Pharmabiz

Abbott's Proclaim XR recharge-free neurostimulation system receives US FDA approval for people living with chronic pain

Abbott announced the US Food and Drug Administration (FDA) has approved the company's Proclaim XR recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform ...
Nasdaq

Abbott Says FDA Oks Proclaim XR Spinal Cord Stimulation System To Treat DPN

(RTTNews) - Abbott Laboratories, Inc. (ABT) announced Thursday that the U.S. Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful ...
Business Insider

FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more effective ...
Monthly Prescribing Reference

Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...
Pharmabiz

US FDA approves expanded MRI compatibility for Abbott's Proclaim XR Spinal Cord Stimulation System

Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR Spinal Cord ...